Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Gut & Barrier Research
Larazotide is a capsule research product containing 500MCG per capsule with 60 capsules per bottle, designed for laboratory investigations involving intestinal barrier pathway research, tight-junction signaling models, epithelial permeability biology, gut-barrier response systems, inflammatory...
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch LZ01
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by Freedom Diagnostics, an independent third-party laboratory, before release. Below is the report for lot LZ01, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Side by side
Peer-reviewed literature
Every reference below is a published, peer-reviewed record, linked to its PubMed entry. Provided for educational reference only - not product claims.
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Encapsulated research material
Larazotide is a capsule research product containing 500MCG per capsule with 60 capsules per bottle, designed for laboratory investigations involving intestinal barrier pathway research, tight-junction signaling models, epithelial permeability biology, gut-barrier response systems, inflammatory pathway research, immune-gut interface models, and gastrointestinal cellular signaling.
Disguised Alpha Larazotide is supplied in a finished capsule format for researchers who require microgram-strength labeling clarity, consistent capsule presentation, professional manufacturing standards, internal QA review, and direct in-house fulfillment.
| Compound | Larazotide |
|---|---|
| Strength | 500MCG per capsule |
| Count | 60 capsules |
| Format | finished capsule research product |
Studied in models involving tight-junction signaling, epithelial barrier behavior, and paracellular permeability pathway research.
Microgram-strength capsule format with clear labeling for controlled laboratory models requiring consistent product presentation.
Larazotide is studied in laboratory models involving intestinal epithelial barrier systems, tight-junction signaling, paracellular permeability biology, gut-barrier response pathways, and inflammatory signaling environments.
Tight-junction pathway research is important in controlled laboratory models because epithelial barrier behavior influences how researchers study permeability, gut-barrier integrity, immune-gut signaling, and gastrointestinal cellular response systems.
The 500MCG capsule format gives researchers a clearly labeled microgram-strength presentation for studies involving barrier-response comparison, epithelial pathway behavior, and gastrointestinal signaling models under controlled experimental conditions.
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Examined junctional-protein distribution, actin rearrangement and barrier measurements. Model-specific results do not validate the finished capsule formulation.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
It is the stated quantity per unit, separate from the number of units in the bottle. A purity percentage is not a measurement of milligrams per capsule or tablet. Use the matching lot report for the measurements actually performed.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy